Topic
Contract Pharmacies
12 published works
Drug & Device Law
Utah Court Sides With Prescription Drug Manufacturers On 340B Contract Pharmacies
We recently attended the ACI Drug & Medical Device Seminar in New York, where we always enjoy catching up with old friends, making new acquaintances, and hearing what’s new in…
Medicaid & Medicare: A Legal Blog
April Fools’ Day and the Supreme Court: A 340B Comedy of Errors
Happy April Fools’ Day! In a move that shocked absolutely no one (except maybe a few overconfident pharmaceutical executives), the U.S. Supreme Court decided in December 2024 that it would…
Health Care Law Today
The Future of the 340B Program: 2023 Key Decisions
By Anil Shankar, Stephanie J. Schwartz, Adria Warren
Critical decisions are pending before courts and legislators in 2023 that promise to shape the future of the 340B Drug Pricing Program (340B Program), which provides discounts on outpatient drugs…
Medicaid and the Law
District Courts Issue Key Decisions in 340B Contract Pharmacy Cases
Over the last two weeks we have seen a flurry of activity from U.S. District Courts across the country in the ongoing contract pharmacy disputes between pharmaceutical manufacturers and HRSA,…
Healthcare Law Blog
340B Drug Pricing Discount Program Update: HRSA Now Demands That Drug Manufacturers Provide 340B Discounts To Contract Pharmacies Amid Ongoing Litigation
By Erica Kraus, Stephanie Awanyai-Ufondu
Now approaching a year-long battle, drug manufacturers and 340B covered entities, which include hospitals and community health centers, participating in the 340B Drug Pricing Discount Program (“340B Participants”) continue to…
Medicaid and the Law
Summer Reruns: ‘340B Contract Pharmacy Saga’ Back in the Spotlight as OGC Withdraws Advisory Opinion
Like the Brood X cicadas emerging from their 17-year chthonic slumber, summer 2021 saw the reemergence of something else set to dominate headlines: 340B contract pharmacies. Given the link between…
Healthcare Law Insights
340B Update: HRSA Notifies Six Manufacturers that They are in Violation of the 340B Statute
By Tiffany A. Hetland, Pete Enko
Since mid-2020, many pharmaceutical manufacturers have introduced policies that scope their offering of 340B pricing, including limiting contract pharmacy arrangements and requiring covered entities to submit claims data. These policies…
Medicaid and the Law
The 340B Contract Pharmacy Saga Continues
Hello readers of Medicaid and the Law! First and foremost, we here at the blog would like to wish our readers a very happy and healthy new year. We are…
To Be or Not to 340B Blog
The End of a Wild Year for 340B: HHS Issues Advisory Opinion and New GAO Report Sheds Light on HRSA’s Enforcement Pullback
By Brenda Maloney Shafer, Richard Davis, David Blank
2020 was a tumultuous year for virtually everyone and everything, and the 340B Program was no exception. As we outlined in previous articles, many drug manufacturers have decided that the…
Medicaid and the Law
The 340B Contract Pharmacy Saga
We are back again with another 340B post. The 340B program has recently been a regular feature on the blog in the context of ongoing litigation discussed here and here.…